Delivery Order SPE2DX22D0010-SPE2D824FNL03

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methylphenidate ER 27 mg tablets. The firm-fixed-price contract is valued at $1,921.46 and has a period of performance through May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,677.27 to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564222527 - Methylphenidate ER 18 mg tablets in 100-count bottles. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,022.52 firm-fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4564327423 - Methylphenidate ER 18 mg Tablets in 100-count bottles. This delivery order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $1,787.40 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the provision of 4,563,637,880 milligrams of the drug Methylphenidate ER 18 mg tablets, with a completion date of February 13, 2024. This order is placed under Amerisourcebergen Drug Corp's single award indefinite delivery...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,840,466 units of Methylphenidate ER 27 mg tablets. The contract has a completion date of March 5, 2024 and a potential value of $4,013.20. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,372,283 methylphenidate ER 36 mg tablets in 100-count bottles. The $1,722.22 delivery order contract has an ultimate completion date of April 10, 2024 and was awarded on April 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,473.95 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the provision of Methylphenidate ER 18 mg tablets, with a completion date of February 20, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,731,300 units of Methylphenidate ER 18 mg tablets. The contract, valued at $1,894.65, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to the agency. This award is...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,170.09 firm fixed-price contract is for the supply of 4,563,289,730 units of Methylphenidate ER 18 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FNL03
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide methylphenidate hydrochloride tablets in 10mg dosage. The $1,559.76 firm-fixed-price contract has a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation.

Generated 9/17/24, 10:11 AM